Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Haemonetics (HAE)

Haemonetics EVP of Global Manufacturing Josep Llorens to retire July 11, 2025

Neutral Impact 3 of 5 leadership Written later

Haemonetics said Executive Vice President of Global Manufacturing and Supply Chain Josep Llorens will retire effective July 11, 2025. He will stay in his role while the company searches for a successor and will help the CEO with the transition until he leaves. The change involves a named executive officer in charge of manufacturing and supply chain, but the filing gives no financial impact.

Key points

  • Josep Llorens, Executive Vice President, Global Manufacturing and Supply Chain, will retire effective July 11, 2025
  • Llorens will remain in his current role while the company searches for a successor
  • Llorens will assist CEO Christopher A. Simon with the transition until his retirement

The filing

CompanyHaemonetics (HAE)
Form8-K, current report
Filed with the SECJan 3, 2025, 6:08 AM ET
Accession number0000313143-25-000003

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 03, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.